Liulin County Chuizhiqihang Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Liulin County Chuizhiqihang Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SQYROY. The owner is based in Liulin, Shanxi.

No. 045

Wangjiahui Village, Lijiawan Township

Liulin, Shanxi 033300 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SQYROY
SQYROY
Registered 2020

Trademark Classifications

Liulin County Chuizhiqihang Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Liulin County Chuizhiqihang Trading Co., Ltd. have?

Liulin County Chuizhiqihang Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Liulin County Chuizhiqihang Trading Co., Ltd. file in?

Liulin County Chuizhiqihang Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Liulin County Chuizhiqihang Trading Co., Ltd.'s most well-known trademarks?

Liulin County Chuizhiqihang Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as SQYROY. These are among 1 currently registered trademark in the portfolio.

What is Liulin County Chuizhiqihang Trading Co., Ltd.'s trademark registration success rate?

Liulin County Chuizhiqihang Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.